BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26759148)

  • 21. Phosphaturic Mesenchymal Tumors in the Head and Neck Demonstrate a Broad Clinical and Morphologic Spectrum.
    Hulme KR; Mahar A; Campbell RG; Clifton-Bligh R; Gill AJ; Palme CE; Gupta R
    Head Neck Pathol; 2022 Sep; 16(3):902-912. PubMed ID: 35119617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphaturic mesenchymal tumor of the nasal cavity and paranasal sinuses: A clinical curiosity presenting a diagnostic challenge.
    Kane SV; Kakkar A; Oza N; Sridhar E; Pai PS
    Auris Nasus Larynx; 2018 Apr; 45(2):377-383. PubMed ID: 28579442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-induced osteomalacia in association with PTEN-negative Cowden syndrome.
    Berglund JA; Gafni RI; Wodajo F; Cowen EW; El-Maouche D; Chang R; Chen CC; Guthrie LC; Molinolo AA; Collins MT
    Osteoporos Int; 2018 Apr; 29(4):993-997. PubMed ID: 29380000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
    Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors.
    Carter JM; Caron BL; Dogan A; Folpe AL
    Am J Surg Pathol; 2015 Jan; 39(1):75-83. PubMed ID: 25025444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and immunohistopathologic study of phosphaturic mesenchymal tumor].
    Li DM; Wu HW; Li JD; Xia WB; Jiang Y; Zhong DR
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):427-431. PubMed ID: 29886586
    [No Abstract]   [Full Text] [Related]  

  • 27. Tumor-induced osteomalacia: An overview.
    Jadhav SS; Shah R; Patil V
    Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101834. PubMed ID: 37935612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: A case report.
    Qiu S; Cao LL; Qiu Y; Yan P; Li ZX; Du J; Sun LM; Zhang QF
    Medicine (Baltimore); 2017 Apr; 96(17):e6750. PubMed ID: 28445300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia.
    Puthenveetil PJ; Hattab EM; Peacock M; Horn EM
    J Clin Neurosci; 2013 Aug; 20(8):1057-61. PubMed ID: 23618679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.
    Colazo JM; DeCorte JA; Gillaspie EA; Folpe AL; Dahir KM
    Bone Rep; 2021 Jun; 14():100744. PubMed ID: 33490314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracranial phosphaturic mesenchymal tumors. A case report and review of literature.
    Kojima D; Ohba S; Abe M; Suzuki A; Horibe S; Tateya I; Hasegawa M; Hirose Y
    Neuropathology; 2022 Oct; 42(5):453-458. PubMed ID: 35880350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
    Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
    Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Phosphaturic Mesenchymal Tumor Presenting as Reversible Metabolic Myopathy.
    Abdulla M
    Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):666-670. PubMed ID: 38725216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report.
    Zhang Y; Hu M; Guo C; Yang X; Xiang S; Xu H
    Front Endocrinol (Lausanne); 2024; 15():1373794. PubMed ID: 38689735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oncogenic osteomalacia due to phosphaturic mesenchymal tumour in infratemporal fossa].
    Viscasillas G; Maiz J; Lao X; Zschaeck C; Sanz JJ
    Acta Otorrinolaringol Esp; 2010; 61(5):392-4. PubMed ID: 20172500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-induced osteomalacia caused by a massive phosphaturic mesenchymal tumor of the acetabulum: A case report.
    Nakamura K; Ohishi M; Matsunobu T; Nakashima Y; Sakamoto A; Maekawa A; Oda Y; Iwamoto Y
    Mod Rheumatol; 2018 Sep; 28(5):906-910. PubMed ID: 27141918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple phosphaturic mesenchymal tumors associated with oncogenic osteomalacia: case report and review of the literature.
    Peterson NR; Summerlin DJ; Cordes SR
    Ear Nose Throat J; 2010 Jun; 89(6):E11-5. PubMed ID: 20556724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.
    Kim I; Rajani R
    J Foot Ankle Surg; 2016; 55(2):294-8. PubMed ID: 25441266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-induced Osteomalacia due to a Phosphaturic Mesenchymal Tumor in the Cervical Spine: A Case Report and Literature Review.
    Agarwal N; Kale SS; Kumari K
    Neurol India; 2019; 67(5):1334-1340. PubMed ID: 31744971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphaturic mesenchymal tumor of the brain without tumor-induced osteomalacia in an 8-year-old girl: case report.
    Ellis MB; Gridley D; Lal S; Nair GR; Feiz-Erfan I
    J Neurosurg Pediatr; 2016 May; 17(5):573-7. PubMed ID: 26722864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.